As Acting Director of CDER’s Office of Regulatory Policy (ORP), Carol Bennett, J.D., helps oversee the development and implementation of regulations, policies, and procedures that affect nearly every aspect of the Center for Drug Evaluation and Research (CDER).
When not in an acting position, Ms. Bennett is the deputy director of ORP. Ms. Bennett has also served as the Acting Director of CDER’s Office of Compliance, where she led efforts to protect the American public from unsafe and ineffective drug products by ensuring that companies comply with federal standards for quality and safety. Before joining ORP, Ms. Bennett served as the Acting Assistant Commissioner for Compliance Policy in the Office of Regulatory Affairs (ORA). In this role, she served as principal advisor in ORA in matters related to developing and implementing compliance policy.
Before joining FDA, Ms. Bennett served for 10 years as Deputy Associate Attorney General for Program Integrity, Office of General Counsel, Centers for Medicare and Medicaid Services. She counseled on program integrity issues and served as a liaison with the Department of Justice regarding the investigation and litigation of False Claims Act and other program integrity matters.
Ms. Bennett holds a bachelor’s degree in political science from the University of Dayton and a juris doctor degree from Harvard Law School.